Class II · Moderate risk Terminated
Liothyronine Sodium Tablets
Reason Failed Impurities/Degradation Specifications
Liothyronine Sodium Tablets
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Failed Impurities/Degradation Specifications: 3 month stability testing.
What was recalled
Liothyronine Sodium Tablets, USP, 5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0220-01,
- Recalling firm
- L. Perrigo Co.
- NDC code
- 0574-0220-01
- Origin
- MI, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-318-2013
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Liothyronine recalls
See all
Class II · Moderate risk Terminated
Liothyronine Sodium Tablets
Reason Failed Impurities/Degradation Specifications.
Class II · Moderate risk Terminated
Liothyronine Sodium Tablets
Reason Failed Impurities/Degradation Specifications.
Class II · Moderate risk Terminated
Nature-Throid 1 GR
Reason CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the same conditions as products found to be sub-potent.
Class II · Moderate risk Terminated
Nature-Throid
Reason CGMP Deviations
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.